Benjamin (Hrsg.) Bonavida
Resistance to Immunotherapeutic Antibodies in Cancer
Strategies to Overcome Resistance
Buch
The current application of antibody-meditated targeted therapy against cancer has resulted in significant objective clinical responses, prolongation of survival and even cures. More than 20 mAbs have been approved for human use targeting a range of different cancers. However, a major drawback of mAb therapeutics is that a subset of patients does not initially respond and another initially responding subset develops resistance to further treatments. At the present time, there are no effective therapies for these subsets of cancer patients. The analyses of underlying mechanisms responsible for resistance are necessary to develop and generate ne…
Mehr
Beschreibung
The current application of antibody-meditated targeted therapy against cancer has resulted in significant objective clinical responses, prolongation of survival and even cures. More than 20 mAbs have been approved for human use targeting a range of different cancers. However, a major drawback of mAb therapeutics is that a subset of patients does not initially respond and another initially responding subset develops resistance to further treatments. At the present time, there are no effective therapies for these subsets of cancer patients. The analyses of underlying mechanisms responsible for resistance are necessary to develop and generate new targeted therapies that overcome the resistance. Resistance to Immunotherapeutic Antibodies in Cancer: Strategies to Overcome Resistance is a timely volume that deals with various mechanisms of resistance to anti-cancer mAbs therapeutics as well as it deals with novel approaches to overcome resistance. The reviews in this volume are written by highly qualified, established and experienced leaders in the field of resistance to anti-cancer mAbs.
CHF 223.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V301:
Libri-Titel folgt in ca. 2 Arbeitstagen
Produktdetails
- ISBN: 978-1-4614-7653-5
- EAN: 9781461476535
- Produktnummer: 14727773
- Verlag: Springer-Verlag GmbH
- Sprache: Englisch
- Erscheinungsjahr: 2013
- Seitenangabe: 202 S.
- Masse: H24.1 cm x B16.0 cm x D1.6 cm 494 g
- Abbildungen: Book; 14 schwarz-weiße und 15 farbige Abbildungen
- Gewicht: 494
Über den Autor
Dr. Benjamin Bonavida is a professor at UCLA's David Geffen School of Medicine for the Department of Microbiology, Immunology, & Molecular Genetics. His other appointments include being a member of the Department of Defense Congressionally Directed Medical Research Program, Member of the National Cancer Institute's SPORE Program, member of the International Scientific Advisory Board of the Israel Cancer Research Foundation, to name a few. He's currently a scientific reviewer for several journals and a member of editorial boards including Journal of Clinical Immunology, International Journal of Oncology, and Cancer Biotherapy & Radiopharmaceuticals. In his career, he's published over 450 papers and reviews, and he's also edited two books with Springer in the past. For more information, please see the CV attached herewith.
34 weitere Werke von Benjamin (Hrsg.) Bonavida:
Strategies to Overcome Resistance
Ebook (PDF Format)
CHF 165.50
Strategies to Overcome Resistance
Ebook (PDF Format)
CHF 154.50
Strategies to Overcome Resistance
Ebook (EPUB Format)
CHF 169.00
Strategies to Overcome Resistance
Ebook (PDF Format)
CHF 165.50
Strategies to Overcome Resistance
Ebook (EPUB Format)
CHF 199.95
Strategies to Overcome Resistance
Ebook (EPUB Format)
CHF 169.00
Strategies to Overcome Resistance
Ebook (EPUB Format)
CHF 212.85
Strategies to Overcome Resistance
Ebook (EPUB Format)
CHF 169.00
Strategies to Overcome Resistance
Ebook (PDF Format)
CHF 187.50
Strategies to Overcome Resistance
Ebook (PDF Format)
CHF 165.50
Bewertungen
0 von 0 Bewertungen
Anmelden
Keine Bewertungen gefunden. Seien Sie der Erste und teilen Sie Ihre Erkenntnisse mit anderen.